A medication originally used for patients with diabetes is the first to help people with Heart Failure and could revolutionise treatment, according to new research from the University of East Anglia. Early research had shown that Sodium-glucose co-transporter-2 (SGLT2) inhibitors could help around half of heart failure patients – those with a condition known as reduction ejection fraction. But new findings published today show that the medication could be beneficial for all heart failure patients – including those with a second type of heart failure called preserved ejection fraction. It is the first drug to provide a real benefit in

Diabetes medication could revolutionise Heart Failure Treatment as seen on The Hippocratic Post.